Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Electrocardiol. 2016 Jul 28;49(6):848–854. doi: 10.1016/j.jelectrocard.2016.07.020

Table 1.

Select studies investigating association between ECG parameters and cardiovascular outcomes among persons on hemodialysis

Author
(Year)
Patients
(n)
ECG
Parameter
Time on HD Mean
Age (yrs)
% Male % CAD % LVH Mean
LVEF (%)
Study Findings
Genovesi
(2013) [11]
122 QTc 3 yrs* 71* 65 38 -- 60* QTc >450 ms in men and >460 ms in women associated with total mortality
(adjusted HR 2.16, p=0.011) and SCD (adjusted HR 8.33, p=0.009).
Hage
(2010) [17]
280 QTc 19 mo 53 62 63 47 47 QTc associated with total mortality (adjusted HR 1.008 per 1 ms increase in
QTc, p=0.016). SCD not assessed.
Beaubien
(2002) [18]
147
(49 on HD)
QT
dispersion
≥ 3 mo 59 62 35 -- 69% with
LVEF >60%
Corrected QT dispersion ≥74 ms associated with total mortality (adjusted HR
1.53 per 50 ms increase, p=0.001) and cardiovascular mortality (adjusted HR
1.57 per 50 ms increase, p=0.028), but not SCD/fatal arrhythmia (p=0.061)
Nakamura
(2005) [51]
48
(all with
cardiac
symptoms)
QT
dispersion
3.9 yrs 61 83 54 -- -- Post-HD corrected QT dispersion associated with cardiovascular mortality
(adjusted HR 1.02 per 1 ms increase, p<0.05), but not with total mortality
(p=0.66). SCD not assessed.
Guney
(2014) [52]
72 QT
dispersion
> 6 mo 44 46 -- -- -- Corrected QT dispersion associated with total mortality (adjusted HR 1.03 per 1
ms increase, p=0.01). SCD not assessed.
de Bie
(2013) [21]
277 Spatial
QRS-T angle
139 d 56 62 25 20 -- Spatial QRS-T angle as ≥130° in men and ≥116° in women associated with total
mortality (adjusted HR 2.33, p<0.01) and SCD (adjusted HR 2.99, p=0.04).
Tereshchenko
(2016) [22]
358 Spatial
QRS-T angle
< 6 mo 55 59 37 75 66 Spatial QRS-T angle ≥75° associated with all-cause mortality (adjusted HR 2.38,
p=0.001), cardiovascular mortality (adjusted HR 2.99, p=0.01), and SCD
(adjusted HR 4.52, p=0.03).
Roithinger
(1992) [26]
50 SAECG 33 mo 55 58 10 78 -- Abnormal SAECG not associated with cardiovascular or arrhythmic mortality
Tereshchenko
(2016) [22]
358 SAECG < 6 mo 55 59 37 75 66 Abnormal SAECG not associated with all-cause mortality, CV mortality, or SCD.
Hayano
(1994) [35]
31 HRV: TI 9 yrs 56 74 45 71 60 TI <22 associated with total mortality (adjusted HR 8.1, p<0.05), and SCD
(adjusted HR 12.6, p<0.05). TI strongest predictor of SCD (better than CAD,
LVEF, ventricular tachycardia). SDNN not associated with SCD after
multivariable adjustment.
Fukuta
(2003) [50]
120 HRV: TI and
ULF Power
50 mo 61 51 6 -- -- TI associated with cardiac mortality (adjusted HR 3.28 per 1 standard deviation
decrease, p<0.05). Log transformed ULF power associated with cardiac
mortality (adjusted HR 1.92 per 1 standard deviation decrease, p<0.05). LF/HF
power ratio and SDNN not associated with cardiac mortality.
Oikawa
(2009) [33]
383 HRV: SDNN 5 y 57 57 -- -- 65 SDNN <75 ms associated with total mortality (adjusted HR 2.18, p<0.001) and
cardiovascular mortality (adjusted HR 2.11, p=0.01). SDNN also associated with
total mortality and cardiovascular death as continuous variable.
Nishimura
(2010) [34]
196 HRV: LF/HF
Power ratio
91 mo 65 58 -- 100 56 Increased LF/HF power ratio associated with SCD (adjusted HR 1.42, p<0.001).
SCD-free survival at 5 years: 98.1% if LF/HF power ratio <1.9 and 29.4% if LF/HF
power ratio ≥1.9.
Green
(2012) [39]
48 TWA 2.7 yrs 63 53 16 -- 63 No association between TWA and total mortality or combined endpoint of
major cardiovascular events or death. SCD not assessed.
*

Median value

Abbreviations: LVEF-left ventricular ejection fraction; LVH-left ventricular hypertrophy; CAD-coronary artery disease; HD-hemodialysis; ULF-ultra-low frequency; TI-triangular index; SDNN-standard deviation of RR intervals; HR-hazard ratio; TWA-T wave alternans; QTc-corrected QT interval; HRV-heart rate variability; LF-low frequency; HF-high frequency